Alginate capsules in a functional cure for diabetes – mapping of immune responses
- Prosjektnummer
- 46037000
- Ansvarlig person
- Berit Løkensgaard Strand
- Institusjon
- NTNU, IKM
- Prosjektkategori
- Forskerstipend 2010
- Helsekategori
- Metabolic and Endocrine
- Forskningsaktivitet
- 5. Treatment Developement
The induction of cytokines by polycation containing microspheres by a complement dependent mechanism.
Biomaterials 2013 Jan;34(3):621-30. Epub 2012 okt 24
PMID: 23103159
Advances in biocompatibility and physico-chemical characterization of microspheres for cell encapsulation.
Adv Drug Deliv Rev 2014 Apr;67-68():111-30. Epub 2013 jul 20
PMID: 23876549
Alginate microencapsulation of human islets does not increase susceptibility to acute hypoxia.
J Diabetes Res 2013;2013():374925. Epub 2013 des 1
PMID: 24364039
Sustained function of alginate-encapsulated human islet cell implants in the peritoneal cavity of mice leading to a pilot study in a type 1 diabetic patient.
Diabetologia 2013 Jul;56(7):1605-14. Epub 2013 apr 26
PMID: 23620058
Survival of human islets in microbeads containing high guluronic acid alginate crosslinked with Ca2+ and Ba2+.
Xenotransplantation 2012 Nov-Dec;19(6):355-64.
PMID: 23198731
Binding and leakage of barium in alginate microbeads.
J Biomed Mater Res A 2012 Nov;100(11):2939-47. Epub 2012 jun 14
PMID: 22700168
A recommended laparoscopic procedure for implantation of microcapsules in the peritoneal cavity of non-human primates.
J Surg Res 2011 Jun;168(1):e117-23. Epub 2011 feb 20
PMID: 21435661
Alginate microbeads are complement compatible, in contrast to polycation containing microcapsules, as revealed in a human whole blood model.
Acta Biomater 2011 Jun;7(6):2566-78. Epub 2011 mar 12
PMID: 21402181
Functionalization of alginate using a chemoenzymatic strategy
Keystonesymposia, Islet Biology, March 2012, Monterey, CA, USA
- Jose Oberholzer Prosjektdeltaker
- Bård Eirik Kulseng Prosjektdeltaker
- Terje Espevik Prosjektdeltaker
eRapport er utarbeidet av Sølvi Lerfald og Reidar Thorstensen, Regionalt kompetansesenter for klinisk forskning, Helse Vest RHF, og videreutvikles av de fire RHF-ene i fellesskap, med støtte fra Helse Vest IKT
Alle henvendelser rettes til Helse Midt-Norge RHF - Samarbeidsorganet og FFU